Global Health Ltd

Global Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Global Health Ltd

₹ 1,085 1.01%
07 Nov - close price
medanta.org BSE: 543654 NSE: MEDANTA
About

Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.[1]

Key Points

** Hospital Count**[1] Global Health has 5 hospitals in operation (Gurugram, Indore, Ranchi, Lucknow, and Patna), and 1 hospital under construction (Noida) under the ‘’Medanta’’ Brand.
Company provides healthcare services in 30+ medical specialties and engages 1,300+ doctors, spanning an area of 4.7 msf.
Operational hospitals have 2,467 installed beds.
They also operate 6 multi-specialty clinics at DLF Cybercity Gurugram, Delhi Airport, south Delhi, Darbhanga, Patna, and Subhash Chowk Gurugram.[2]

Website BSE NSE
  • Market Cap ₹ 29,139 Cr.
  • Current Price ₹ 1,085
  • High / Low ₹ 1,514 / 842
  • Stock P/E 60.4
  • Book Value ₹ 108
  • Dividend Yield 0.00 %
  • ROCE 19.3 %
  • ROE 17.9 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company has delivered good profit growth of 56.2% CAGR over last 5 years

Cons

  • Stock is trading at 10.0 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE Healthcare Nifty 500 Multicap 50:25:25 BSE 400 MidSmallCap Index Nifty LargeMidcap 250 BSE 250 LargeMidCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
485 583 521 617 679 694 707 780 844 836 809 861
386 448 441 485 522 534 540 595 631 620 629 675
Operating Profit 100 136 80 133 157 160 167 184 213 216 179 186
OPM % 21% 23% 15% 21% 23% 23% 24% 24% 25% 26% 22% 22%
6 10 12 9 16 12 25 15 21 18 27 22
Interest 16 18 28 19 18 21 20 18 20 18 18 18
Depreciation 31 33 35 36 37 39 38 40 43 44 45 47
Profit before tax 58 95 29 87 117 112 133 141 171 172 143 144
Tax % 28% 26% 40% 33% 27% 28% 24% 28% 27% 28% 11% 26%
42 70 18 59 86 81 101 102 125 124 127 106
EPS in Rs 8.39 2.76 0.69 2.32 3.38 3.01 3.77 3.80 4.66 4.61 4.74 3.96
Raw PDF
Upcoming result date: 14 November 2024

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
1,382 1,343 1,456 1,500 1,447 2,167 2,694 3,275 3,350
1,081 1,218 1,283 1,309 1,250 1,709 2,073 2,476 2,556
Operating Profit 301 125 172 192 197 458 621 799 794
OPM % 22% 9% 12% 13% 14% 21% 23% 24% 24%
45 49 50 44 31 39 64 75 88
Interest 14 28 38 57 73 86 86 74 74
Depreciation 70 86 102 115 123 130 150 173 179
Profit before tax 262 60 83 64 32 281 449 627 630
Tax % 35% 45% 38% 43% 11% 30% 27% 24%
170 33 51 36 29 196 326 478 482
EPS in Rs 35.10 6.78 10.44 7.36 5.81 7.75 12.16 17.81 17.97
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 18%
3 Years: 31%
TTM: 17%
Compounded Profit Growth
10 Years: %
5 Years: 56%
3 Years: 155%
TTM: 31%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 26%
Return on Equity
10 Years: %
5 Years: 12%
3 Years: 16%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 48 48 49 49 50 51 54 54
Reserves 976 1,136 1,246 1,300 1,333 1,565 2,375 2,852
165 456 787 929 931 1,109 1,122 802
295 343 347 388 380 421 547 597
Total Liabilities 1,485 1,984 2,430 2,666 2,694 3,146 4,097 4,304
914 1,094 1,194 1,703 1,616 1,776 2,050 2,237
CWIP 12 317 666 382 464 439 327 386
Investments 0 0 0 0 0 0 0 0
559 573 570 581 615 930 1,720 1,681
Total Assets 1,485 1,984 2,430 2,666 2,694 3,146 4,097 4,304

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
228 63 166 175 242 311 645 612
-241 -69 -249 -87 -239 -421 -342 -441
-7 9 97 -1 -81 160 346 -514
Net Cash Flow -20 3 14 87 -78 50 648 -343

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 20 41 41 36 34 30 26 24
Inventory Days 28 26 26 43 42 36 35 32
Days Payable 92 124 142 147 138 90 114 90
Cash Conversion Cycle -45 -56 -75 -67 -62 -24 -52 -34
Working Capital Days -23 -15 -11 -22 -22 -2 -18 -13
ROCE % 6% 6% 5% 15% 17% 19%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
33.08% 33.08% 33.07% 33.06% 33.05% 33.04% 33.04% 33.04%
9.36% 9.89% 10.58% 10.69% 11.36% 12.10% 12.94% 12.21%
12.55% 12.34% 10.79% 10.93% 11.15% 10.25% 10.57% 11.11%
45.01% 44.67% 45.55% 45.31% 44.45% 44.60% 43.44% 43.64%
No. of Shareholders 1,21,4071,07,1201,09,7981,16,6271,24,7751,66,2531,55,3071,49,722

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls